BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $182,000 | +271.4% | 2,235 | +253.1% | 0.00% | +100.0% |
Q3 2018 | $49,000 | -94.1% | 633 | -95.1% | 0.00% | -94.7% |
Q1 2018 | $832,000 | -29.7% | 12,797 | -30.2% | 0.02% | -20.8% |
Q4 2017 | $1,184,000 | -78.7% | 18,322 | -79.4% | 0.02% | -78.9% |
Q3 2017 | $5,569,000 | +127.8% | 88,743 | +119.7% | 0.11% | +128.0% |
Q2 2017 | $2,445,000 | +484.9% | 40,388 | +400.6% | 0.05% | +525.0% |
Q1 2017 | $418,000 | -56.9% | 8,068 | -63.1% | 0.01% | -55.6% |
Q4 2016 | $969,000 | -27.7% | 21,856 | -26.2% | 0.02% | -41.9% |
Q2 2016 | $1,340,000 | +42.9% | 29,625 | +29.7% | 0.03% | +47.6% |
Q1 2016 | $938,000 | +179.2% | 22,840 | +159.7% | 0.02% | +250.0% |
Q4 2015 | $336,000 | -60.0% | 8,795 | -65.6% | 0.01% | -60.0% |
Q3 2015 | $839,000 | +139.7% | 25,539 | +399.5% | 0.02% | +150.0% |
Q1 2015 | $350,000 | – | 5,113 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |